Phase 2a study of CM-101, a CCL24 neutralizing antibody, in patients with non-alcoholic steatohepatitis: a proof-of-concept study

Safadi, R; Lawler, J; Aricha, R; Vaknin, I; Friedman, S; Mor, A

JOURNAL OF HEPATOLOGY, 2023; 78 (): S119

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索